Skip to main content
ANIK logo

ANIK · Anika Therapeutics, Inc. · Documents

Track ANIK — free
$13.62 +0.77 (+5.99%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$182.44M
Shares
13.40M
Volume · Nov 18 119.01K Avg daily vol (3M) 107.13K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Mar 15
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $166.66M ▲ 6.7% Net loss $82.67M Diluted EPS -$5.64
2023
Mar 16
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $156.24M ▲ 5.7% Net loss $14.86M Diluted EPS -$1.02
2022
Mar 11
Annual report 10-K FY2021, ended Dec 31
Annual report for FY2021
Revenue $147.79M ▲ 13.3% Net income $4.13M Diluted EPS $0.28
Showing 51–100 of 150 documents
Key facts CIK 898437 CUSIP 035255108 13F (30d) 141 filings 126 filers Visit website Investor relations